4D Molecular Therapeutics
FDMT
FDMT
124 hedge funds and large institutions have $141M invested in 4D Molecular Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 59 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $262M → $141M (-$121M)
54% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 37
Holders
124
Holding in Top 10
–
Calls
$156K
Puts
$129K
Top Buyers
| 1 | +$6.11M | |
| 2 | +$4.03M | |
| 3 | +$1.45M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.18M |
| 5 |
Two Sigma Advisers
New York
|
+$1.18M |
Top Sellers
| 1 | -$7.35M | |
| 2 | -$6.83M | |
| 3 | -$6.41M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.31M |